A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2009
11/11/2009	EP1320369B1 A method of analgesia
11/11/2009	EP1317286B1 Administration form for hormonal contraception
11/11/2009	EP1317278B1 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
11/11/2009	EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same
11/11/2009	EP1242118B1 Methods of treating central nervous system ischemic or hemorrhagic injury using anti alpha4 integrin antagonists
11/11/2009	EP1196163B1 Pharmaceutical compositions for the treatment of insulin resistance
11/11/2009	EP1191943B1 Anti-allergic peptides
11/11/2009	EP1181048B1 A pharmaceutical formulation containing an inhibitor of carboxypeptidase u and a thrombin inhibitor
11/11/2009	EP1158976B1 VACUOLAR-TYPE (H+)-ATPase-INHIBITING COMPOUNDS, COMPOSITIONS, AND USES THEREOF
11/11/2009	CN101578098A Drug, drug induction device, magnetic detector and method of designing drug
11/11/2009	CN100558903C Photochemical internalization for delivery of molecules into the cytosol
11/11/2009	CN100558883C New strains of bifidobacterium having the ability to produce glutamine
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009	CN100558411C Tenascin-C nucleic acid ligands
11/11/2009	CN100558410C Nucleic acids, polypeptides, and methods for modulating apoptosis
11/11/2009	CN100558407C Preparation of aqueous clear solution dosage forms with bile acids
11/11/2009	CN100558402C Stomach dissolution type pharmaceutical composition and its preparation method
11/11/2009	CN100558395C Hybrid peptide modulate immune response
11/11/2009	CN100558368C Method and material for treating immune diseases
11/11/2009	CN100558367C Method for enhancing the effectiveness of cancer therapies
11/11/2009	CN100558364C Combination of brimonidine and timolol for topical ophthalmic use
11/11/2009	CN100558359C Remedy for glomerular diseae
11/11/2009	CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/11/2009	CN100558350C Improved transdermal delivery system
11/10/2009	US7615679 Method of producing polyunsaturated fatty acids, novel biosynthesis genes, and novel plant expression constructs
11/10/2009	US7615574 Comprises chlorogenic acid and 3-o-p-Coumaryl quinic acid isolated from any plant parts of Piper betel
11/10/2009	US7615553 E.g., N,N-dimethyl,((5-(hydroxyaminocarbonyl)pyrimidin-2-yl)(piperazin-1,4-ylene)sulfonamide; bioavailability; oral administration; metabolic stability; side effect reduction; psoriasis; anticarcinogenic -proliferative, -arthritic, -inflammatory agent; gene therapy; genetic transcription potentiation
11/10/2009	US7615548 Method to inhibit ischemia and reperfusion injury
11/10/2009	US7615545 Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
11/10/2009	US7615543 Complexes with C-reactive protein (CRP) molecules; rheumatoid arthritis, juvenile chronic (rheumatoid) arthritis, ankylosing spondylitis, psoriatic arthritis, systemic vasculitis, polymyalgia rheumatica, Reiter's disease, Crohn's disease and familial Mediterranean fever
11/10/2009	US7615542 Dioxolane thymine and combinations for use against 3TC/AZT resistant strains of HIV
11/10/2009	US7615379 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
11/10/2009	US7615341 Using allelic mutation on human chromosome 8 as diagnostic indicator of degenerative joint disease
11/10/2009	US7615237 Percutaneously absorbable preparations
11/10/2009	US7615210 Treatment of endometriosis
11/10/2009	US7615207 Methods for treating irritable bowel syndrome
11/10/2009	US7615030 Apparatus and method for administering a therapeutic agent into tissue
11/10/2009	CA2444145C Preparation of formulations of angiotensin ii at1 receptors antagonists for the treatment of arterial hypertension, other cardiovascular illness and its complications
11/10/2009	CA2396351C New therapeutic combinations of (s)-2-(benzylamino-methyl)-2,3,8,9,-tetrahydro-7h-1,4-dioxino[2,3-e]indol-8-one and neuroleptics for the treatment or prevention of psychotic disorders
11/10/2009	CA2371213C Inhibitors of carboxypeptidase u
11/10/2009	CA2186953C Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
11/09/2009	CA2631071A1 Inhibition of calpain reduces allergic inflammation
11/05/2009	WO2009134713A1 Compositions and methods for male contraception
11/05/2009	WO2009133863A1 Immunopotentiating agent comprising ep1 agonist
11/05/2009	WO2009133142A1 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
11/05/2009	WO2009133141A2 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis
11/05/2009	WO2009101497A3 Topical pharmaceutical combination comprising minoxidil and aminexil
11/05/2009	WO2009090648A3 Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents
11/05/2009	WO2009002829A3 Tableted compositions containing atazanavir
11/05/2009	WO2009002826A3 Tableted compositions containing atazanavir
11/05/2009	WO2009002823A3 Tableted compositions containing atazanavir
11/05/2009	WO2009002821A3 Tableted compositions containing atazanavir
11/05/2009	WO2008127659A3 Anticancer combination of a dac inhibitor and a tyrosine kinase inhibitor
11/05/2009	US20090275872 Fluid wound dressing comprising partially cured polyurethane
11/05/2009	US20090275664 Novel polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/05/2009	US20090275545 Medicinal targeted local lipolysis
11/05/2009	US20090275041 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/05/2009	US20090274784 Aqueous extract of stems or leaves or stems and leaves of one or more Cissus quandragularis plants to promote weight loss; combined with chitosan and amylase inhibitor
11/05/2009	US20090274775 reducing the risk of suicide associated with the use of a psychoactive drug by administering a lithium salt as cotherapy with said psychoactive drug
11/05/2009	US20090274774 Citrate-Based Dialysate Chemical Formulations
11/05/2009	US20090274773 Antiproliferative combination comprising cyc-682 and a cytotoxic agent
11/05/2009	US20090274712 Compositions for coating cell membranes and methods of use thereof
11/05/2009	US20090274707 Anti-IL-12 Antibodies, Nucleic Acids Encoding Antibodies, and Methods of Production
11/05/2009	US20090274703 Methods of treating inflammation using IL-17 antagonists
11/05/2009	US20090274688 Antibodies to OPGL
11/05/2009	US20090274680 Human Phospholipases
11/05/2009	US20090274669 Dendritic Cells Transiently Transfected with a Membrane Homing Polypeptide and their use
11/05/2009	US20090274662 Methods And Kits For The Treatment Of Inflammatory Bowel Disorder Conditions
11/05/2009	US20090274656 Hepatitis c virus inhibitors
11/05/2009	US20090274654 Methods and devices for the sustained release of multiple drugs
11/05/2009	US20090274653 Interleukin-2 mutants with reduced toxicity
11/05/2009	US20090274650 Inhibitors of aspartyl protease
11/05/2009	CA2722815A1 Use of dronedarone for preparing a medicament for the treatment of patients with arrhythmia and having an increase of creatinine level due to dronedarone administration
11/05/2009	CA2722453A1 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of angiogenesis
11/05/2009	CA2722314A1 New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response
11/05/2009	CA2721560A1 Combination of dronedarone with at least one diuretic, and therapeutic use thereof
11/04/2009	EP2113566A1 Genes from 20q13 amplicon and their uses
11/04/2009	EP2113254A1 Compositions for treating an inflammatory auto-immune condition
11/04/2009	EP2112930A2 Modulation of nkt cell activity with antigen-loaded cdid molecules
11/04/2009	EP2112920A1 Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
11/04/2009	EP1499311B1 Substituted benzazoles and use thereof as raf kinase inhibitors
11/04/2009	EP1490121B1 Drug delivery particle
11/04/2009	EP1481077B1 Mitotic kinesin inhibitors
11/04/2009	EP1467743B1 Pharmaceutical combinations comprising a fungicide, a bacteriostatic sulphonamide and an antibacterial compound for topical application
11/04/2009	EP1420645B1 Multivesicular emulsion topical delivery systems
11/04/2009	EP1372638B1 Cannabinoids for the treatment of breathing disorders during sleep
11/04/2009	EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009	EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009	EP1303488B1 Piperidine compounds for use as ccr-3 inhibitors
11/04/2009	EP1011695B2 Use of neurotoxin therapy for treatment of prostate disorders
11/04/2009	CN101573108A Particles of paclitaxel and albumin in combination with bevacizumab against cancer
11/03/2009	US7612109 Water-soluble iron-carbohydrate complexes, production thereof, and medicaments containing said complexes
11/03/2009	US7612093 With (-)-2'-deoxy-3'-thiocytidine-5'-triphosphate; immunomodulators; nucleosides
11/03/2009	US7612058 Administering 1-(4-fluorophenyl)-3(R)-[3(S)-(4-fluorophenyl)-3-hydroxypropyl)]-4(S)-[4-(phenylmethoxy)phenyl]-2-azetidinone; and peroxisome proliferator-activated receptor activator; obesity, antidiabetic agents
11/03/2009	US7612052 Combinations comprising epothilones and pharmaceutical uses thereof
11/03/2009	US7612038 Stabilizing dystrophin associated protein complexes; abnormal synapses or neuromuscular junction disorders
11/03/2009	US7612034 Administering calcitonin and dehydroepiandrosterone (DHEA) to patient being treated for systemic lupus erythematosus where the immunosuppressant tends to reduce bone mineral density(BMD); osteoporosis
11/03/2009	US7612033 administering to the cell a composition which comprises the compound to be delivered and an organic halide such as a perfluorocarbon; ultrasound
11/03/2009	US7611910 Determining whether cerebralspinal fluid sample contains Chlamydia pneumoniae
11/03/2009	US7611896 Protein-free medium comprising agent that balances the oncotic pressure across semipermeable cell membranes for use detecting parasitic infection; immunodiagnostics

1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 1151